ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $492,000 | -24.8% | 30,400 | -3.5% | 1.04% | +134.6% |
| Q3 2018 | $654,000 | +36.0% | 31,500 | 0.0% | 0.44% | +10.8% |
| Q2 2018 | $481,000 | -32.1% | 31,500 | 0.0% | 0.40% | -39.3% |
| Q1 2018 | $708,000 | -29.8% | 31,500 | -5.9% | 0.66% | -23.0% |
| Q4 2017 | $1,008,000 | -20.0% | 33,460 | 0.0% | 0.85% | -13.8% |
| Q3 2017 | $1,260,000 | +41.9% | 33,460 | +5.0% | 0.99% | +50.9% |
| Q2 2017 | $888,000 | -74.4% | 31,861 | -68.5% | 0.66% | -85.0% |
| Q1 2017 | $3,472,000 | -53.3% | 100,994 | -56.8% | 4.38% | -43.9% |
| Q3 2016 | $7,436,000 | -20.8% | 233,772 | -19.2% | 7.81% | -10.5% |
| Q2 2016 | $9,393,000 | +44.5% | 289,380 | +24.4% | 8.72% | +49.8% |
| Q1 2016 | $6,502,000 | +110.8% | 232,546 | +168.7% | 5.82% | +85.5% |
| Q4 2015 | $3,085,000 | +19.9% | 86,544 | +34.0% | 3.14% | +15.6% |
| Q2 2015 | $2,574,000 | -16.4% | 64,566 | -33.4% | 2.71% | +23.7% |
| Q4 2014 | $3,078,000 | -41.7% | 96,959 | -54.6% | 2.19% | -48.3% |
| Q3 2014 | $5,284,000 | +273.4% | 213,428 | +240.8% | 4.24% | +294.0% |
| Q2 2014 | $1,415,000 | -86.4% | 62,620 | -85.3% | 1.08% | -88.6% |
| Q1 2014 | $10,373,000 | -35.2% | 426,329 | -33.4% | 9.43% | -8.7% |
| Q4 2013 | $16,007,000 | – | 640,531 | – | 10.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |